PlainRecalls
FDA Drug Critical Class I Terminated

Acyclovir Sodium Injection 1000mg/20mL (50mg/mL) vial NDC 68382-049-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 20mL Single-Dose Vials per pack NDC 68382-049-10, Rx only, Manufactured by: Cadila Healthcare Ltd., Vadodara, India. Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.

Reported: April 7, 2021 Initiated: February 18, 2021 #D-0315-2021

Product Description

Acyclovir Sodium Injection 1000mg/20mL (50mg/mL) vial NDC 68382-049-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 20mL Single-Dose Vials per pack NDC 68382-049-10, Rx only, Manufactured by: Cadila Healthcare Ltd., Vadodara, India. Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.

Reason for Recall

Crystallization: customer complaints for crystallization in finished product.

Details

Units Affected
816 packs
Distribution
USA Nationwide
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
Acyclovir Sodium Injection 1000mg/20mL (50mg/mL) vial NDC 68382-049-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 20mL Single-Dose Vials per pack NDC 68382-049-10, Rx only, Manufactured by: Cadila Healthcare Ltd., Vadodara, India. Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.. Recalled by Zydus Pharmaceuticals (USA) Inc. Units affected: 816 packs.
Why was this product recalled?
Crystallization: customer complaints for crystallization in finished product.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 7, 2021. Severity: Critical. Recall number: D-0315-2021.